One of the most important prerequisites of the successful implementation of pharmacogenomics into the clinic is the increase of the general public’s awareness over the benefits of pharmacogenomics in rationalizing drug use.
Recognizing this fact, the Golden Helix Foundation organizes in London the 1st UPGx Personalized Medicine Public Day. The meeting will be organized in the Royal Society and is part of the dissemination and outreaching activities of the Ubiquitous Pharmacogenomics (UPGx) project, funded by the European Commission (H2020-668353).
This event is meant for the general public, patient organisations, regulators, insurers and policy makers.
On behalf of the Organizing Committee